Learn More About
Gene Silencing Technology
And Personalised Cancer Testing.
REAL PATIENT STORY
Location · Changzhou, China
Cancer · Diffuse Large B-Cell Lymphoma (DLBCL)
Diagnosis · Non-Hodgkin Lymphoma
Patient · Anonymous
Approach · Personalised testing and Gene Silencing Technology
After initially discovering an enlarged lymph node, the patient underwent biopsy and further examination at the hospitals.
The diagnosis was diffuse large B-cell lymphoma, a type of non-Hodgkin lymphoma.
What followed was a difficult period involving chemotherapy, significant side effects, and concerns about the impact of treatment on her quality of life.
Together with her husband, she began looking for another approach.
WHEN SOMETHING DIDN'T FEEL RIGHT
It Started
With a Lump
In August 2025, she noticed an enlarged lymph node while taking a shower.
At first, she thought it was simply inflammation. But after two weeks, the lump was still there.
A biopsy at Hospital confirmed non-Hodgkin lymphoma, later identified as diffuse large B-cell lymphoma (DLBCL).
Further examination at the hospital confirmed the diagnosis.
“At first, I thought it was just an enlarged lymph node.”
THE DIAGNOSIS AND CHEMOTHERAPY
When Treatment
Became Difficult.
Following her diagnosis, she began chemotherapy combined with targeted therapy.
She completed two rounds of chemotherapy but experienced significant side effects, including fatigue, poor appetite, difficulty sleeping, and low white blood cell counts.
Her husband watched her struggle through the treatment and began questioning whether there could be another option.
“It was very, very hard.”
A DIFFERENT DIRECTION
They Started
Looking for Another Way.
After two rounds of chemotherapy, the couple decided not to continue with a third round.
They began searching for another approach that they felt would be less physically demanding.
Through a doctor, they were introduced to Gene Silencing Technology and its personalised approach.
Their medical reports, including pathology and PET/CT results, were reviewed before they proceeded.
“I wanted to find a new approach.”
HER EXPERIENCE WITH GENE SILENCING TECHNOLOGY
A More
Personalised Approach.
The couple described a very different experience with Gene Silencing Technology.
According to the patient, the infusion took around 30 minutes. She experienced only a mild reaction approximately two hours later, including a slight feverish feeling and warmth in her hands and feet.
The reaction gradually subsided and did not prevent her from continuing her daily activities.
Personalised testing was also used to help select the nutrients included in her programme.
“I was Happy I have a direction.”
THE FOLLOW-UP RESULTS
The Results
Changed What They Expected.
The couple later received a follow-up PET/CT at Hospital.
The original lymph node measured approximately 5 × 4 cm.
According to their account, the follow-up scan showed that one previously affected lymph-node area had disappeared, while the other had reduced to within the normal range.
The reported metabolic activity had essentially disappeared, with a 5-PS score of 1.
“The result completely exceeded what we expected.”
They continue to view regular follow-up and monitoring as an important part of their journey.
Understanding Cancer.
Exploring What Comes Next
Every cancer journey is unique.
Their experience led them to explore a personalised approach with Gene Silencing Technology.
It Started
With a Lump.
In August 2025, she noticed an enlarged lymph node while taking a shower.
At first, she thought it was simply inflammation. But after two weeks, the lump was still there.
A biopsy at Changzhou Second People's Hospital confirmed non-Hodgkin lymphoma, later identified as diffuse large B-cell lymphoma (DLBCL).
Further examination at Shanghai Ruijin Hospital confirmed the diagnosis.
When Treatment
Became Difficult.
Following her diagnosis, she began chemotherapy combined with targeted therapy.
She completed two rounds of chemotherapy but experienced significant side effects, including fatigue, poor appetite, difficulty sleeping, and low white blood cell counts.
Her husband watched her struggle through the treatment and began questioning whether there could be another option.
They Started
Looking for Another Way.
After two rounds of chemotherapy, the couple decided not to continue with a third round.
They began searching for another approach that they felt would be less physically demanding.
Through a doctor, they were introduced to Q-REstrain and its personalised approach.
Their medical reports, including pathology and PET/CT results, were reviewed before they proceeded.
A More
Personalised Approach.
The couple described a very different experience with Q-REstrain.
According to the patient, the infusion took around 30 minutes. She experienced only a mild reaction approximately two hours later, including a slight feverish feeling and warmth in her hands and feet.
The reaction gradually subsided and did not prevent her from continuing her daily activities.
Personalised testing was also used to help select the nutrients included in her programme.
The Results Changed What They Expected.
The couple later received a follow-up PET/CT at Changzhou Second People's Hospital.
The original lymph node measured approximately 5 × 4 cm.
According to their account, the follow-up scan showed that one previously affected lymph-node area had disappeared, while the other had reduced to within the normal range.
The reported metabolic activity had essentially disappeared, with a 5-PS score of 1.
They continue to view regular follow-up and monitoring as an important part of their journey.
When You Want to Understand More.
Every cancer diagnosis brings questions. For this patient, finding answers meant looking beyond the information she already had.
She began researching online, learning more about cancer testing and exploring information that could help her better understand her individual cancer journey.
Interested to know more about Gene Silencing Technology?
WhatsApp us to learn more about it!
How to Reach Us
We offer multiple ways to contact us, ensuring you can reach us through your preferred method.
+852 4750 3485
Email Us
info@mycancerinfo.org
Send Us a Message
- The statements expressed above are solely the personal experiences and opinions of the patient and do not represent the medical stance, advice, or endorsement of our company or website.
- Every patient’s medical condition, cancer genetics, and response to therapy are profoundly unique. Individual results from testing and treatment will vary.
